title: HIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particles.
abstract: Nef is an important player for viral infectivity and AIDS progression, but the mechanisms involved are not completely understood. It was previously demonstrated that Nef interacts with GagPol through p6*-Protease region. Because p6* and Protease are involved in processing, we explored the effect of Nef on viral Protease activity and virion assembly. Using in vitro assays, we observed that Nef is highly capable of inhibiting Protease activity. The IC50 for nef-deficient viruses in drug susceptibility assays were 1.7- to 3.5-fold higher than the wild-type counterpart varying with the type of the Protease inhibitor used. Indicating that, in the absence of Nef, Protease is less sensitive to Protease inhibitors. We compared the protein content between wild-type and nef-deficient mature viral particles by gradient sedimentation and observed up to 2.7-fold reduction in the Integrase levels in nef-deficient mature particles. This difference in levels of Integrase correlated with the difference in infectivity levels of wild type and nef-deficient viral progeny. In addition, an overall decrease in the production of mature particles was detected in nef-deficient viruses. Collectively, our data support the hypothesis that the decreased infectivity typical of nef-deficient viruses is due to an abnormal function of the viral Protease, which is in turn associated with less mature particles being produced and the loss of Integrase content in these particles, and these results may characterize Nef as a regulator of viral Protease activity.
authors.affiliation: Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Luiza M
authors.initials: LM
authors.lastname: Mendonça
authors.affiliation: Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Sandro C
authors.initials: SC
authors.lastname: Poeys
authors.affiliation: Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Celina M
authors.initials: CM
authors.lastname: Abreu
authors.affiliation: Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Amilcar
authors.initials: A
authors.lastname: Tanuri
authors.affiliation: Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Luciana J
authors.initials: LJ
authors.lastname: Costa
mesh_terms: D002460:Cell Line; D015693:Gene Products, nef / Q000378:metabolism*; D016333:HIV Protease / Q000378:metabolism*; D015497:HIV-1 / Q000378:metabolism*; D006801:Humans; D014771:Virion
chemical_list: D015693:Gene Products, nef; D016333:HIV Protease
references.citation: J Virol. 1997 Aug;71(8):5774-81
references.pmid: 9223465
references.citation: Eur J Biochem. 1994 Apr 15;221(2):811-9
references.pmid: 8174561
references.citation: Virology. 2006 Aug 1;351(2):322-39
references.pmid: 16684552
references.citation: J Biomed Sci. 1998 Jul-Aug;5(4):305-8
references.pmid: 9691224
references.citation: J Virol. 1999 Feb;73(2):1460-7
references.pmid: 9882352
references.citation: Nature. 1991 Apr 11;350(6318):508-11
references.pmid: 2014052
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Sep;60(Pt 9):1625-7
references.pmid: 15333937
references.citation: Virology. 1997 Aug 4;234(2):215-25
references.pmid: 9268152
references.citation: J Virol. 2004 Oct;78(19):10588-97
references.pmid: 15367626
references.citation: J Virol. 1986 Mar;57(3):1159-62
references.pmid: 2419583
references.citation: J Virol. 2001 Dec;75(24):12081-7
references.pmid: 11711598
references.citation: J Med Virol. 2007 Feb;79(2):127-37
references.pmid: 17177310
references.citation: J Virol. 2007 Sep;81(18):10037-46
references.pmid: 17626089
references.citation: Adv Pharmacol. 2007;55:347-87
references.pmid: 17586320
references.citation: J Virol. 2003 Apr;77(7):4409-14
references.pmid: 12634398
references.citation: J Virol. 1999 Jan;73(1):436-43
references.pmid: 9847349
references.citation: Virology. 1995 Feb 1;206(2):854-65
references.pmid: 7856098
references.citation: J Virol. 1993 Jul;67(7):4050-5
references.pmid: 8510215
references.citation: Retrovirology. 2005 Nov 01;2:66
references.pmid: 16262906
references.citation: J Virol. 2005 Aug;79(16):10601-7
references.pmid: 16051852
references.citation: Retrovirology. 2006 Jun 09;3:33
references.pmid: 16764724
references.citation: J Virol. 1996 Dec;70(12):9051-4
references.pmid: 8971042
references.citation: Andrologia. 1998;30 Suppl 1:41-7
references.pmid: 9629442
references.citation: Expert Opin Ther Targets. 2009 Aug;13(8):895-908
references.pmid: 19534569
references.citation: Proteins. 2001 Jun 1;43(4):455-64
references.pmid: 11340661
references.citation: Retrovirology. 2013 Jul 30;10:80
references.pmid: 23899341
references.citation: EMBO Rep. 2001 Jul;2(7):580-5
references.pmid: 11463741
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6812-7
references.pmid: 17412836
references.citation: J Virol. 1986 Aug;59(2):284-91
references.pmid: 3016298
references.citation: Virology. 1998 Nov 25;251(2):302-16
references.pmid: 9837795
references.citation: J Clin Microbiol. 2009 Jul;47(7):2232-42
references.pmid: 19403770
references.citation: J Virol. 2012 Dec;86(24):13708-16
references.pmid: 23055560
references.citation: J Virol. 1995 Aug;69(8):5048-56
references.pmid: 7541845
references.citation: J Virol. 2004 Aug;78(16):8477-85
references.pmid: 15280456
references.citation: Ann N Y Acad Sci. 1990;616:73-85
references.pmid: 2078037
references.citation: J Virol. 2003 Oct;77(19):10548-56
references.pmid: 12970439
references.citation: J Virol. 1994 Oct;68(10):6782-6
references.pmid: 8084015
references.citation: J Virol. 2010 Apr;84(8):3935-48
references.pmid: 20147394
references.citation: J Virol. 1995 Jul;69(7):4112-21
references.pmid: 7769669
references.citation: J Virol. 1999 Mar;73(3):2126-35
references.pmid: 9971795
references.citation: FEBS Lett. 1995 Jan 9;357(3):275-8
references.pmid: 7835426
references.citation: Virology. 1993 Apr;193(2):661-71
references.pmid: 7681610
references.citation: J Exp Med. 1994 Jan 1;179(1):101-13
references.pmid: 8270859
references.citation: Virology. 1995 Oct 1;212(2):451-7
references.pmid: 7571414
references.citation: Protein Sci. 1994 Jun;3(6):888-97
references.pmid: 8069220
references.citation: Retrovirology. 2007 Dec 28;4:96
references.pmid: 18163907
references.citation: Eur J Biochem. 1994 Jul 15;223(2):589-93
references.pmid: 8055930
references.citation: Proteins. 2010 Mar;78(4):1015-25
references.pmid: 19899162
references.citation: J Virol. 2004 May;78(10):5311-23
references.pmid: 15137387
references.citation: J Virol. 2001 Apr;75(8):3971-6
references.pmid: 11264386
references.citation: Mol Biol Cell. 2007 Sep;18(9):3351-65
references.pmid: 17581864
references.citation: Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4776-80
references.pmid: 1647017
references.citation: Cell. 2006 Jun 16;125(6):1055-67
references.pmid: 16777597
references.citation: J Virol. 2008 May;82(9):4573-84
references.pmid: 18321978
references.citation: J Virol. 1995 Jul;69(7):4053-9
references.pmid: 7539505
references.citation: J Gen Virol. 2006 Jul;87(Pt 7):2041-2046
references.pmid: 16760407
references.citation: J Virol. 1992 May;66(5):2943-51
references.pmid: 1313911